Bayer AG (FRA:BAYN) has been given a €124.00 ($137.78) price target by analysts at Deutsche Bank AG in a report released on Wednesday. The firm currently has a a “buy” rating on the stock.

Other equities analysts have also recently issued reports about the company. Bankhaus Lampe set a €103.00 ($114.44) price objective on Bayer AG and gave the company a “buy” rating in a research note on Wednesday, June 29th. equinet AG set a €118.00 ($131.11) price objective on Bayer AG and gave the company a “buy” rating in a research note on Friday, July 15th. Goldman Sachs Group Inc. set a €129.00 ($143.33) price objective on Bayer AG and gave the company a “buy” rating in a research note on Wednesday. JPMorgan Chase & Co. restated a “neutral” rating on shares of Bayer AG in a research note on Wednesday. Finally, Commerzbank AG set a €110.00 ($122.22) price objective on Bayer AG and gave the company a “buy” rating in a research note on Wednesday. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of €112.17 ($124.63).

Bayer AG (FRA:BAYN) opened at 92.205 on Wednesday. The company has a 50 day moving average of €95.47 and a 200 day moving average of €95.90. The firm has a market capitalization of €76.25 billion and a P/E ratio of 16.934. Bayer AG has a 1-year low of €83.87 and a 1-year high of €127.21.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/deutsche-bank-ag-analysts-give-bayer-ag-bayn-a-124-00-price-target-2.html

About Bayer AG

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.